Alpha 2.0
Login Register
» Authors » Francois Maurier

Francois Maurier

Explore the profile of Francois Maurier including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 93
Citations 2128
Followers 0
Related Specialties
Rheumatology
Allergy & Immunology
General Medicine
Top 10 Co-Authors
Loic Guillevin
Benjamin Terrier
Xavier Puechal
Luc Mouthon
Bernard Bonnotte
Olivier Aumaitre
Eric Hachulla
Maxime Samson
Pascal Godmer
Pascal Cohen
Published In
Rheumatology (Oxford)
Autoimmun Rev
RMD Open
Ann Rheum Dis
Arthritis Rheumatol
Affiliations
Soon will be listed here.
Recent Articles
1.
Characterisation of a high-risk profile for maternal thrombotic and severe haemorrhagic complications in pregnant women with antiphospholipid syndrome in France (GR2): a multicentre, prospective, observational study
Murarasu A, Guettrot-Imbert G, Le Guern V, Yelnik C, Queyrel V, Schleinitz N, et al.
Lancet Rheumatol . 2024 Jan; 4(12):e842-e852. PMID: 38261392
Background: Prospective data about the risks of thrombotic and severe haemorrhagic complications during pregnancy and post partum are unavailable for women with antiphospholipid syndrome. We aimed to assess thrombotic and...
2.
Pregnancy outcomes in women with primary Sjögren's syndrome: an analysis of data from the multicentre, prospective, GR2 study
Martin de Fremont G, Costedoat-Chalumeau N, Lazaro E, Belkhir R, Guettrot-Imbert G, Morel N, et al.
Lancet Rheumatol . 2024 Jan; 5(6):e330-e340. PMID: 38251600
Background: Adverse pregnancy outcomes in women with primary Sjögren's syndrome have only been evaluated retrospectively using heterogeneous methods and with contradictory results. We aimed to describe adverse pregnancy, delivery, and...
3.
Rituximab as maintenance therapy for ANCA-associated vasculitides: pooled analysis and long-term outcome of 277 patients included in the MAINRITSAN trials
Delestre F, Charles P, Karras A, Pagnoux C, Neel A, Cohen P, et al.
Ann Rheum Dis . 2023 Nov; 83(2):233-241. PMID: 37918894
Objective: To compare the long-term efficacy and safety of azathioprine (AZA), 18-month fixed-schedule rituximab (RTX), 18-month tailored RTX and 36-month RTX in preventing relapses in patients with antineutrophil cytoplasmic antibody...
4.
In inflammatory myopathies, dropped head/bent spine syndrome is associated with scleromyositis: an international case-control study
Pijnenburg L, Giannini M, Bouchard-Marmen M, Arnaud L, Barsotti S, Bellando-Randone S, et al.
RMD Open . 2023 Sep; 9(3). PMID: 37666644
Background: Some myopathies can lead to dropped head or bent spine syndrome (DH/BS). The significance of this symptom has not been studied in inflammatory myopathies (IM). Objectives: To assess the...
5.
Health-related quality of life, remission and low lupus disease activity state in patients with systemic lupus erythematosus
Thibault T, Rajillah A, Bourredjem A, Corneloup M, Maurier F, Wahl D, et al.
Rheumatology (Oxford) . 2023 Aug; 63(5):1447-1455. PMID: 37589711
Objectives: To measure the association between SLE remission and scores of patients-reported outcome (PRO) measures. Methods: We performed a prospective cohort study of SLE patients with a 2-year follow-up, using...
6.
Clinical features and long-term outcomes of patients with systemic polyarteritis nodosa diagnosed since 2005: Data from 196 patients
Rohmer J, Nguyen Y, Trefond L, Agard C, Allain J, Berezne A, et al.
J Autoimmun . 2023 Aug; 139:103093. PMID: 37536165
Background: The landscape of polyarteritis nodosa (PAN) has substantially changed during the last decades. Recent data regarding causes, characteristics, and prognosis of systemic PAN in the modern era are lacking....
7.
Regulatory T-cell dysfunctions are associated with increase in tumor necrosis factor α in autoimmune hemolytic anemia and participate in Th17 polarization
Ciudad M, Ouandji S, Lamarthee B, Cladiere C, Ghesquiere T, Nivet M, et al.
Haematologica . 2023 Aug; 109(2):444-457. PMID: 37534543
Warm autoimmune hemolytic anemia (wAIHA) is a rare acquired autoimmune disease mediated by antibodies targeting red blood cells. The involvement of CD4 T-helper cells has been scarcely explored, with most...
8.
Mouth opening in systemic sclerosis: A longitudinal analysis from the French National Cohort Study
Chaigne B, Bense A, Agard C, Allanore Y, Pugnet G, Hachulla E, et al.
J Intern Med . 2023 Jun; PMID: 37376708
Background: Few studies have evaluated mouth opening (MO) in systemic sclerosis (SSc). None have studied MO trajectories. Objective: To study MO trajectories in SSc. Methods: This multicentre study included patients...
9.
Effect of weight-adjusted intermediate-dose versus fixed-dose prophylactic anticoagulation with low-molecular-weight heparin on venous thromboembolism among noncritically and critically ill patients with COVID-19: the COVI-DOSE trial, a multicenter,...
Zuily S, Lefevre B, Sanchez O, Empis de Vendin O, De Ciancio G, Arlet J, et al.
EClinicalMedicine . 2023 Jun; 60:102031. PMID: 37350990
Background: Venous thromboembolism is a major complication of coronavirus disease 2019 (COVID-19). We hypothesized that a weight-adjusted intermediate dose of anticoagulation may decrease the risk of venous thromboembolism COVID-19 patients....
10.
Intravenous versus subcutaneous tocilizumab in Takayasu arteritis: multicentre retrospective study
Mekinian A, Biard L, Lorenzo D, Novikov P, Salvarani C, Espitia O, et al.
RMD Open . 2023 Jun; 9(2). PMID: 37321669
Objectives: In this large multicentre study, we compared the effectiveness and safety of tocilizumab intravenous versus subcutaneous (SC) in 109 Takayasu arteritis (TAK) patients. Methods: We conducted a retrospective multicentre...